Lars Taavola (’02) Expands Patent Parameters

Mallinckrodt Pharmaceuticals is a 150-plus-year-old company that needed help transitioning to a twenty-first century world both from a legal and a leadership perspective. Enter Lars Taavola, who joined the company during August of 2020 as vice president and chief intellectual property counsel, focused on refining Mallinckrodt’s IP strategy.